Oral / Combo Weight Loss Treatments

Several oral and combination treatments are available. These treatments are comprised of several complimentary medications that focus on specific elements promoting weight loss, energy gain, metabolic efficiency and fat/cholesterol breakdowns in your body. Combined with our nutritional and fitness program, these treatments are perfect for patients looking to accelerate their weight loss with an easy to swallow daily pill or combination of oral medications, topical sprays, creams or peptide therapies.

Advanced Oral GLP-1 Therapies for Weight and Metabolic Health

Once-a-day oral weight loss options now include two FDA-approved brand-name tablets: the Wegovy® pill (oral semaglutide, Novo Nordisk) and Foundayo (orforglipron, Eli Lilly). Compounded oral options are also available. Your provider will help you compare effectiveness, cost and insurance coverage to choose the right fit.

Oral Tirzepatide

Oral tirzepatide is a compounded formulation for patients who prefer not to use injections. It is designed to support weight loss by targeting the hormones that regulate appetite and blood sugar. It is not FDA-approved, and published evidence on oral tirzepatide is limited. FDA-approved oral alternatives include Foundayo (orforglipron, Eli Lilly) and the Wegovy® pill, and your provider will discuss how each option compares.

Oral Semaglutide

Oral semaglutide is available as the brand-name Wegovy® pill (Novo Nordisk), a once-daily tablet FDA-approved for chronic weight management. It mimics the body’s natural GLP-1 hormone to reduce appetite, improve blood sugar control, and increase feelings of fullness, and is a good option for those who prefer not to use injections. If a compounded formulation is prescribed instead, it is prepared by a licensed pharmacy and is not FDA-approved.

Bupropion/Naltrexone

Bupropion/Naltrexone is a once a day weight loss drug that combines a noradrenaline/dopamine reuptake inhibitor with a non-selective opioid receptor antagonist. Research on the pathways that regulate food intake and body weight has identified the hypothalamic melanocortin system and the mesolimbic reward system, which are the targets of this combination.

Book Consultation Now

All appointments are telehealth visits - done conveniently from wherever you are. Serving patients in Virginia, Maryland, West Virginia and Washington D.C. including Aldie, Alexandria, Ashburn, Herndon, Leesburg, Manassas, Reston, Stone Ridge, Warrenton, Winchester, Baltimore, Columbia, Germanton, Silver Spring, Frederick, Gaithersburg and Bethesda.

Book Now